Japan Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Japan Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026
SUMMARY
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Japanese biotechnology market had total revenues of $65.1 billion in 2021, representing a compound annual growth rate (CAGR) of 12.9% between 2016 and 2021.
- The environment & industrial processing segment generated the most revenue in 2021, with total revenues of $25.3 billion, equivalent to 38.9% of the market's overall value.
- The Japanese market is the second largest in the Asia-Pacific region, accounting for 26.1% of its total value in 2021, ahead of China’s 15.6%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
- What was the size of the Japan biotechnology market by value in 2021?
- What will be the size of the Japan biotechnology market in 2026?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Japan biotechnology industry value: $ billion, 2016–21
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Japan biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Japan biotechnology industry geography segmentation: $ billion, 2021
Table 5: Japan biotechnology industry value forecast: $ billion, 2021–26
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Astellas Pharma Inc.: key facts
Table 11: Astellas Pharma Inc.: Annual Financial Ratios
Table 12: Astellas Pharma Inc.: Key Employees
Table 13: Astellas Pharma Inc.: Key Employees Continued
Table 14: Daiichi Sankyo Co Ltd: key facts
Table 15: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 16: Daiichi Sankyo Co Ltd: Key Employees
Table 17: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 18: Mitsubishi Tanabe Pharma Corporation: key facts
Table 19: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 20: Japan size of population (million), 2017–21
Table 21: Japan gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Japan gdp (current prices, $ billion), 2017–21
Table 23: Japan inflation, 2017–21
Table 24: Japan consumer price index (absolute), 2017–21
Table 25: Japan exchange rate, 2017–21
Table 1: Japan biotechnology industry value: $ billion, 2016–21
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Japan biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Japan biotechnology industry geography segmentation: $ billion, 2021
Table 5: Japan biotechnology industry value forecast: $ billion, 2021–26
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Astellas Pharma Inc.: key facts
Table 11: Astellas Pharma Inc.: Annual Financial Ratios
Table 12: Astellas Pharma Inc.: Key Employees
Table 13: Astellas Pharma Inc.: Key Employees Continued
Table 14: Daiichi Sankyo Co Ltd: key facts
Table 15: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 16: Daiichi Sankyo Co Ltd: Key Employees
Table 17: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 18: Mitsubishi Tanabe Pharma Corporation: key facts
Table 19: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 20: Japan size of population (million), 2017–21
Table 21: Japan gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Japan gdp (current prices, $ billion), 2017–21
Table 23: Japan inflation, 2017–21
Table 24: Japan consumer price index (absolute), 2017–21
Table 25: Japan exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Japan biotechnology industry value: $ billion, 2016–21
Figure 2: Japan biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Japan biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2021
Figure 1: Japan biotechnology industry value: $ billion, 2016–21
Figure 2: Japan biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Japan biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2021
